Altered β-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells

British Journal of Cancer

Volumn 77, Issue 4, 1998, Pages 562-566

  Ranganathan, S ^a   Benetatos, C A ^a   Colarusso, P J ^a   Dexter, D W ^a   Hudes, G R ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; COLCHICINE; DOXORUBICIN; ESTRAMUSTINE; ISOPROTEIN; MESSENGER RNA; PACLITAXEL; VERAPAMIL; VINBLASTINE;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG RESISTANCE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; RADIOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031985608     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.91     Document Type: Article

References (27)

1. Banerjee A, Roach MC. Trcka P and Luduena RF (1990) Increased microtubule assembly in bovine brain tubulin lacking type III isotype of β-tubulin. J Biol Chem 265: 1794-1799
2. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate phenol-chloroform extraction. Anal Biochem 162: 156-159
3. Cross D, Gustavo F, Dominguez J, Avila J and Maccioni RB (1994) Carboxyl terminal sequences of β-tubulin involved in the interaction of HMW-MAPs. Studies using site-specific antibodies. Mol Cell Biochem 32: 81-90
4. Dahllof H, Billstrom A, Cabral F and Hartley-Asp B (1993) Estramustine depolymerizes microtubules by binding to tubulin. Cancer Res 53: 4573-4581
5. Derry WB, Wilson L and Jordan MA (1995) Substoichiometric binding of taxol suppresses microtubule dynamics. Biochemistry 34: 2203-2211
6. Derry WB, Wilson L, Khan IA, Luduena FR and Jordan MA (1997) Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified β-tubulin isotypes. Biochemistry 36: 3554-3562
7. Dhamodharan R, Jordan MA, Thrower D, Wilson LW and Wadsworth P (1995) Vinblastine suppresses dynamics of individual microtubules in living interphase cells. Mol Biol Cell 6: 1215-1229
8. Fontalba A, Avila J and Zabala JC (1995) β-tubulin folding is modulated by the isotype-specific carboxy-terminal domain. J Mol Biol 246: 628-636
9. Giannakakou P, Sackett D, Kang YK, Fojo AT and Poruchynsky M (1996) Tubulin from paclitaxel (PTX) resistant human ovarian carcinoma cell lines demonstrates altered response to drug, in vivo and in vitro (abstract 2176). AACR 87th Annual Meeting, Washington DC, Vol. 37
10. Haber M, Burkhart CA, Regl DL, Madafiglio J, Norris MD and Horwitz SB (1995) Altered expression of Mβ2, the class II β-tubulin isotype, in a murine J774.2 cell line with a high level of taxol resistance. J Biol Chem 270: 31269-31275
11. Horwitz SB, Rao S, Haber M, Burkhart C and Orr GA (1995) The taxol-binding site on the microtubule (abstract). Cytoskeleton and Cancer: Proceedings 42
12. Hudes GR, Nathan FE, Khater C, Haas N, Cornfield M, Giantonio B, Greenberg R, Gomella L, Litwins S, Ross E, Roetmke S and McAleer C (1997) Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer. J Clin Oncol 15: 3156-3163
13. Hudes GR (1997) Estramustine-based chemotherapy. Sem Urol Oncol 15: 13-19
14. Jordan MA, Thrower D and Wilson L (1992) Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles: implications for the role of microtubule dynamics in mitosis. J Cell Sci 102: 401-416
15. Jordan MA, Toso RJ, Thrower D and Wilson L (1993) Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentralions. Proc Natl Acad Sci USA 90: 9552-9556
16. Laing N, Dahllof B, Hartley-Asp B, Ranganathan S and Tew K (1997) Interaction of estramustine with tubulin isotypes. Biochemistry 36: 871-878
17. III isotypes enhances taxol induced microtubule assembly. Cell Struct Funct 18: 173-182
18. Mallarino MC, Duran GE, Dumontet C, Cluck M, Mangili A and Sikic BI (1996) The spectrum of resistance to paclitaxel in human sarcoma and breast cancer cells selected with and without the multidrug resistance (MDR-1) modulator PSC 833 (abstract 2987). AACR 87th Annual Meeting, Washington DC, Vol. 37
19. Panda D, Miller HP, Banerjee A, Luduena RF and Wilson L (1994) Microtubule dynamics in vitro are regulated by the tubulin isotype composition. Proc Natl Acad Sci USA 91: 11358-11362
20. IVa-tubulin isotypes in human prostate carcinoma cells as a result of estramustine resistance. Cancer Res 56: 2584-2589
21. Roth BJ, Yeap BY, Wilding G, Warren J-T, Bokesch H, Kenny S and Boyd MR (1993) Taxol in advanced, hormone-refractory carcinoma of the prostate. A phase II trial of the Eastern Cooperative Oncology Group. Cancer 72: 2457-2460
22. Skehan P, Stoneng R, Scudiero D, Monks A, McMahon J, Vistica D, Kasimis B, McLeod D and Lochler PS (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107-1112
23. Speicher LA, Barone L and Tew K (1992) Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines. Cancer Res 52: 4433-4440
24. Speicher LA, Laing N, Barone LR, Robbins JD, Seamon KB and Tew KD (1994) Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells. Mol Pharmacol 46: 866-872
25. Sullivan KF (1988) Structure and utilization of tubulin isotypes. Annu Rev Cell Biol 4: 687-716
26. Vindelov LL, Christensen IJ and Nissen NI (1983) A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3: 323
27. Zilfou JT and Smith CD (1995) Differential interactions of cytochalasins with P-glycoprotein. Oncol Res 7: 435-443